Institute of Cancer Research

Gene Sequencing Project

New breast cancer study

Annual Research Report

2010/11 online report now available

Science Students

PhD studentships are now available

Clinical Trainees

Opportunities & Support

Current Students

Available Supporting Resources

Staff Development

Training and Learning

Staff Benefits

Welfare and Facilities

Legacies

Contribute to the future.

Student Bursary Programme

Invest in tomorrow.

Opportunities

View our Licensing Portfolio

Successes

ICR’s Enterprise Achievements

Contacts

Get in Touch with Us

News

Report reveals year of research success
[02 February 2012]
The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust have launched their Joint Annual R...

Prostate cancer drug shows impressive new Phase III trial results
[01 February 2012]
Patients with advanced prostate cancer who were given a new type of hormonal treatment called MDV3100 lived an...

Women with faulty BRCA genes more likely to survive ovarian cancer
[24 January 2012]
Ovarian cancer patients who carry BRCA1 or BRCA2 mutations are significantly more likely to survive the diseas...

Musculoskeletal side–effects from breast cancer treatment are not long term
[20 January 2012]
A drug regimen found to cut a women’s risk of dying from breast cancer gives a higher risk of carpal tunnel sy...

Scientists unravel cause of second cancer arising from targeted treatment
[18 January 2012]
Scientists at The Institute of Cancer Research (ICR) have shown how to prevent new cancers which can occur whe...

Scientist wins prestigious fellowship
[10 January 2012]
A scientist from the ICR and The Royal Marsden has received one of four prestigious Cancer Research UK Clinica...

Fewer, Larger Radiotherapy Doses Prove Safe For Prostate Cancer Patients
[13 December 2011]
Less overall radiotherapy, delivered in fewer but higher doses, is as safe as standard, lower doses for treati...

Scientists Discover How To Beat Resistance To Standard Leukaemia Drug
[08 December 2011]
ICR scientists have revealed a technique to kill chronic myeloid leukaemia (CML) cells that have stopped respo...

Scientist Recognised with Cancer Charity’s Highest Honour
[02 December 2011]
The ICR's Professor Mel Greaves has become the first scientist honoured with leading blood cancer charity Leuk...

Topping out ceremony marks milestone for The Royal Marsden and The Institute of Cancer Research
[30 November 2011]
Progress on The Royal Marsden and the ICR's new Centre for Molecular Pathology in Sutton, Surrey, has reached ...